Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
33pct
2d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Next Generation Researchers Act This bill amends the Public Health Service Act to establish the Next Generation of Researchers Initiative in the National Institutes of Health (NIH) to coordinate NIH policies and programs aimed at promoting and providing opportunities for new researchers and earlier research independence. The NIH must: (1) promote policies and programs to improve opportunities for new researchers and promote earlier research independence; (2) develop, modify, or accelerate policies, as needed, to promote opportunities for new researchers and earlier research independence, including policies to enhance training opportunities for research-related career options, strengthen mentorship programs, enhance diversity efforts, and help new researchers obtain renewal funding; (3) coordinate with agencies and academic institutions to improve tracking of career progress of biomedical postdoctoral researchers and students; and (4) request the National Academy of Sciences to conduct a comprehensive study and report on policies affecting the next generation of researchers as part of a study on biomedical and behavioral research personnel.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
P.L. 114-255, 21st Century Cures Act Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. Oppose reduction in Medicare hospital outpatient department reimbursement. Support incorporating sociodemographic status in Hospital Readmissions Reduction Program and addressing mid-build, off-campus outpatient departments under development at the time of enactment of the Bipartisan Budget Act of 2015. Create a crosswalk between Medicare Part A and Part B payments. Issue: Support federal funding for research using fetal tissue and promote security of individuals involved with fetal tissue research. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists, reauthorization of NIH loan repayment program. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. S. 2742, Promoting Biomedical Research and Public Health for Patients Act. Issue: Support reducing regulatory burden on research institutions and scientists. Issue: Support NIHs protection of researchers from sexual harassment Issue: FDA regulation of Laboratory Developed Tests (LDTs) Issue: Support NIH medical research of pain and addiction S. 2953, FY 2017 National Defense Authorization Act Issue: Oppose restrictions on medical research supported by the Department of Defense Submitted comments to: --NIH on the use of preprints and interim research products in NIH applications and reports. --NIH on the use of a single Institutional Review Board (sIRB) for multi-site research.
Client expense: $687,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Health Issues
S 1077 Advancing Breakthrough Devices for Patients S2014 HR3466 Next Generation Researchers Act HR 3731, S 2030 Rare Disease Fund Act of 2015 S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers) HR 34 21st Century Cures Act (formerly HR 6), signed into law
Client expense: $38,669 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
HR 6 21st Century Cures S 1077 Advancing Breakthrough Devices for Patients S2014 HR3466 Next Generation Researchers Act HR 3731, S 2030 Rare Disease Fund Act of 2015 S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers)
Client expense: $58,768 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. Issue: Support federal funding for research using fetal tissue and promote security of individuals involved with fetal tissue research. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists, reauthorization of NIH loan repayment program. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. S. 2742, Promoting Biomedical Research and Public Health for Patients Act. Issue: Support reducing regulatory burden on research institutions and scientists. Issue: Support NIHs protection of researchers from sexual harassment Issue: FDA regulation of Laboratory Developed Tests (LDTs) Issue: Support NIH medical research of pain and addiction S. 2953, FY 2017 National Defense Authorization Act Issue: Oppose restrictions on medical research supported by the Department of Defense Submitted comments to: --NIH on human-animal chimera research. --NIH National Institute of General Medical Sciences (NIGMS) on strategies for modernizing graduate education.
Client expense: $595,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · second_quarter · Health Issues
FY17 LHHS bill FY17 Ag Bill S. 185, Path Act S. 2014/H.R. 3466 Next Generation Researchers Act Ensuring Childrens Access to Specialty Care Act, H.R. 1859/S. 2782
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2016 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. Issue: Support federal funding for research using fetal tissue and promote security of individuals involved with fetal tissue research. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists, reauthorization of NIH loan repayment program. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. S. 2742, Promoting Biomedical Research and Public Health for Patients Act. Issue: Support reducing regulatory burden on research institutions and scientists. Issue: Support NIHs protection of researchers from sexual harassment Issue: FDA regulation of Laboratory Developed Tests (LDTs) Issue: Support NIH medical research of pain and addiction S. 2953, FY 2017 National Defense Authorization Act Issue: Oppose restrictions on medical research supported by the Department of Defense Submitted comments to: --NIH National Institute of General Medical Sciences on Approaches for Supporting Team Science in the Biomedical Research Community
Client expense: $736,000 · Firm income: Not reported
2016 · second_quarter · Health Issues
S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research HR639 Improving Regulatory Transparency for New Medical Therapies Act (signed into law) HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015 (signed into law) HR 2646 S1945 Helping Families in Mental Health Crisis Act of 2015 HR 3731, S 2030 Rare Disease Fund Act of 2015 HR 3729 Limit Fetal Tissue Research S 2141 Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 or TRUST It Act (with respect to health information technology) S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2512 Adding Zika Virus to the FDA Priority Review Voucher Program Act S 1101 Medical Electronic Data Technology Enhancement for Consumers' Health Act S 1767 Combination Product Regulatory Fairness Act of 2015 S 1597 Patient-Focused Impact Assessment Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1945 Mental Health Reform Act of 2015 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2700 FDA and NIH Workforce Authorities Modernization Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers)
2016 · second_quarter · Health Issues
21st Century Cures Act (HR 6), Next Generation Researchers Act (S. 2014, HR 3466), Graduate medical education, NIH funding, Medicare/Recovery Audit Issues (S.2368), Medicare/Accountable Care Organizations, MACRA Implementation (HHS/CMS), NIH Research issues (S. 2014, S. 2742 & S.2745), REGROW Act (S. 2689), the FY2017 Labor, Health and Human Services, and Education and Related Agencies Appropriations Bills (S.3040/H.R._____), the Durbin amendment to the FY2017 National Defense Authorization Act (S.2943) to protect medical research supported by the Department of Defense.
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
2016 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. Issue: Support federal funding for research using fetal tissue and promote security of individuals involved with fetal tissue research. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists, reauthorization of NIH loan repayment program. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. S. 2742, Promoting Biomedical Research and Public Health for Patients Act. Issue: Support reducing regulatory burden on research institutions and scientists. Issue: Support NIHs protection of researchers from sexual harassment Issue: FDA regulation of Laboratory Developed Tests (LDTs) Submitted comments to: NIH National Center for Advancing Translational Sciences (NCATS) on the institutions strategic planning process HHS Office for Human Research Protections regarding the 1991 Common Rule, which governs federally supported research involving human subjects
Client expense: $822,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research HR639 Improving Regulatory Transparency for New Medical Therapies Act (signed into law) HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015 (signed into law) HR 2646 S1945 Helping Families in Mental Health Crisis Act of 2015 HR 3731, S 2030 Rare Disease Fund Act of 2015 HR 3729 Limit Fetal Tissue Research S 2141 Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 or TRUST It Act (with respect to health information technology) S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2512 Adding Zika Virus to the FDA Priority Review Voucher Program Act S 1101 Medical Electronic Data Technology Enhancement for Consumers' Health Act S 1767 Combination Product Regulatory Fairness Act of 2015 S 1597 Patient-Focused Impact Assessment Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1945 Mental Health Reform Act of 2015 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2700 FDA and NIH Workforce Authorities Modernization Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers)
2016 · first_quarter · Health Issues
21st Century Cures Act (HR 6), NIH Administrative Issues/Senate HELP Innovation Initiative, Organ transplantation issues, Indirect Medical Education Funding, Next Generation Researchers Act (S. 2014, HR 3466), Protecting Student Medical Health Records, Graduate Medical education, NIH funding, Medicare/Recovery Audit Issues, Medicare/Accountable Care Organizations, Research Integrity Issues, MACRA Implementation (HHS/CMS), Stark Law Improvements, Presidents Cancer Moonshot, Precision Medicine, Zika Virus, NIH Research issues (S. 2742 & S.2745)
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · first_quarter · Health Issues
FY17 LHHS bill FY17 Ag Bill S. 185, Path Act S. 2014/H.R. 3466 Next Generation Researchers Act
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2015 · third_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps Budget Resolution (S.Con.Res.11) Congressional Budget Resolution Provisions Related to NIH (S.con.res.11/H.con.res.27) FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions H.R.6, 21st Century Cures Act Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: $208,575 · Firm income: Not reported
2015 · third_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps Budget Resolution (S.Con.Res.11) Congressional Budget Resolution Provisions Related to NIH (S.con.res.11/H.con.res.27) FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions H.R.6, 21st Century Cures Act Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: $337,480 · Firm income: Not reported
2015 · fourth_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) H.R.2029 Consolidated Appropriations Act H.R.3762 Restoring Americans Health Care Freedom Reconciliation Act of 2015 Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: $231,228 · Firm income: Not reported
2015 · fourth_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) H.R.2029 Consolidated Appropriations Act H.R.3762 Restoring Americans Health Care Freedom Reconciliation Act of 2015 Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: $231,228 · Firm income: Not reported
2015 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 3466/S. 2014, the Next Generation Researchers Act - provisions related to supporting early career investigators and faster roads to research independence H.R. 2029, the Omnibus Appropriations and Tax Extenders Act - provisions related to funding for research agencies including HHS, NIH H.R. 6, the 21st Century Cures Act - provisions related to the Innovation Fund for NIH, streamlining clinical trials, reducing research administrative burden, and NCATS. S. xxx, the Innovations for Healthier Americans bill - provisions related to NIH funding, regulatory reform, laboratory developed tests, and other policy provisions H.R. 3537, the Synthetic Drug Act - provisions related to restrictions of synthetic drug compounds as they pertain to use by researchers General issues related to the NPRM on the Common Rule Issues related to biomedical research funding, particularly at NIH General issues related to the Precision Medicine Initiative
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) H.R.2029 Consolidated Appropriations Act H.R.3762 Restoring Americans Health Care Freedom Reconciliation Act of 2015 Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: Not reported · Firm income: $231,228
2015 · fourth_quarter · Health Issues
S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research HR639 Improving Regulatory Transparency for New Medical Therapies Act (signed into law) HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015 (signed into law) HR 2646 S1945 Helping Families in Mental Health Crisis Act of 2015 HR 3731 Rare Disease Fund Act of 2015 (Andrew Los brainchild) HR 3729 Limit Fetal Tissue Research S 2141 Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 or TRUST It Act (with respect to health information technology)
Client expense: $58,549 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medical/Disease Research/Clinical Labs
Presidents Budget, FY 2017 Issue: Funding for Agency for Healthcare Research and Quality (AHRQ), NIH Presidents Budget, FY 2016 H.R. 3020/S. 1695, Labor, HHS, Education and Related Agencies Act, 2016, Title II P.L. 114-113, H.R. 2029, Consolidated Appropriations Act, 2016, Division H, Title II Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), biodefense and public health preparedness programs, Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose House proposal to eliminate AHRQ. Oppose rescissions from CMMI and PCORI. President's Budget, FY 2017 H.R. 2029 and draft Senate Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2016 P.L. 114-113, Consolidated Appropriations Act, 2016, Division J, Title II Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Support the use of animals in medical research. Issue: Oppose discretionary spending cuts through sequestration, including NIH and other science programs. Issue: Funding for pandemic preparedness and biodefense programs Issue: Draft legislation on protections for human subjects in research S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 320/H.R. 744, Medical Innovation Act Issue: Requires covered manufacturers of blockbuster drugs developed, in whole or in part, through federal investments in medical research that enter settlement agreements with a federal agency to pay 1 percent of net income over five years to increase congressional investments in biomedical research. S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. Issue: FDA regulation of Laboratory Developed Tests (LDTs) Issue: Support federal funding for research using human fetal tissue. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists. H.R. 3119, draft Senate legislation, Palliative Care and Hospice Education and Training Act Issue: Health professions education on palliative care Submitted comments to: -HRSA on Proposed Omnibus Guidance on 340B Drug Pricing Program -FDA on International Scheduling of Ketamine -NIH on its strategic plan to advance research on the health and well-being of sexual and gender minorities
2015 · fourth_quarter · Science/Technology
Presidents Budget, FY 2017 Issue: Funding for Agency for Healthcare Research and Quality (AHRQ), NIH Presidents Budget, FY 2016 H.R. 3020/S. 1695, Labor, HHS, Education and Related Agencies Act, 2016, Title II P.L. 114-113, H.R. 2029, Consolidated Appropriations Act, 2016, Division H, Title II Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose House proposal to eliminate AHRQ. Oppose rescissions from CMMI and PCORI. President's Budget, FY 2017 H.R. 2029 and draft Senate Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2016 P.L. 114-113, Consolidated Appropriations Act, 2016, Division J, Title II Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Oppose discretionary spending cuts through sequestration, including NIH and other science programs. Issue: Supporting the use of animals in medical research. Issue: Funding for pandemic preparedness and biodefense programs. Issue: Draft legislation on protections for human subjects in research. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 320/H.R. 744, Medical Innovation Act Issue: Requires covered manufacturers of blockbuster drugs developed, in whole or in part, through federal investments in medical research that enter settlement agreements with a federal agency to pay 1 percent of net income over five years to increase congressional investments in biomedical research. S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. Issue: FDA regulation of Laboratory Developed Tests (LDTs) H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists. H.R. 1806, The America COMPETES Act of 2015 Issue: Support increased funding for the National Science Foundation (NSF) Issue: Support federal funding for research using human fetal tissue. Submitted comments to: -FDA on International Scheduling of Ketamine -NIH on strategies to enhance diversity in the physician�scientist workforce -NIH on its strategic plan to advance research on the health and well-being of sexual and gender minorities
2015 · fourth_quarter · Health Issues
21st Century Cures Act (HR 6), NIH Administrative Issues/Senate HELP Innovation Initiative, Organ transplantation issues, Indirect Medical Education Funding, Chronic care management billing/CMS, Next Generation Researchers Act (S. 2014, HR 3466), Protecting Student Medical Health Records, Graduate medical education (H.R. 3292), NIH funding (H.R. 2029), Omnibus Appropriations Act), Medicare/Recovery Audit Issues, Medicare/Accountable Care Organizations, Research Integrity Issues, MACRA Implementation (HHS/CMS), Stark Law Improvements, Hospital Outpatient Department Policy (H.R. 1314, Bipartisan Budget Act), Legislation to prohibit fetal tissue research (HR 3729, HR 3171)
Client expense: $118,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · third_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) American Tax Payer Relief Act (H.R.8) "fiscal cliff bill"-Medicare/Medicaid Therapy Caps Budget Resolution (S.Con.Res.11) Congressional Budget Resolution Provisions Related to NIH (S.con.res.11/H.con.res.27) FY2016 Agriculture Appropriations (S.1800) FY2016 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ and NIH(H.R.3020/ S.1695) House Energy and Commerce Committee Budget Reconciliation Instructions H.R.6, 21st Century Cures Act Next Generation Research Act(S.2014/H.R.3466) Research for All Act(H.R.2101)
Client expense: Not reported · Firm income: $337,480
2015 · third_quarter · Medical/Disease Research/Clinical Labs
Presidents Budget, FY 2017 Issue: Funding for Agency for Healthcare Research and Quality (AHRQ), NIH Presidents Budget, FY 2016 H.R. 3020/S. 1695, House Labor, HHS, Education and Related Agencies Act, 2016, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), biodefense and public health preparedness programs, Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose House proposal to eliminate AHRQ. Oppose rescissions from CMMI and PCORI. President's Budget, FY 2016 H.R. 4486 and draft Senate House Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2015 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Support the use of animals in medical research. Issue: Oppose discretionary spending cuts through sequestration, including NIH and other science programs. Issue: Funding for pandemic preparedness and biodefense programs Issue: Draft legislation on protections for human subjects in research S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 320/H.R. 744, Medical Innovation Act Issue: Requires covered manufacturers of blockbuster drugs developed, in whole or in part, through federal investments in medical research that enter settlement agreements with a federal agency to pay 1 percent of net income over five years to increase congressional investments in biomedical research. S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. Issue: FDA regulation of Laboratory Developed Tests (LDTs) Issue: Support federal funding for research using human fetal tissue. H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists. Submitted comments to: National Institute on Minority Health and Health Disparities (NIMHD) on interdisciplinary training in health disparities science The White House on the Precision Medicine Initiatives proposed privacy and trust principles National Institutes of Health (NIH) on the framework for the NIH-wide Strategic Plan NIMHD on the NIH Science Vision for health disparities research
2015 · third_quarter · Science/Technology
Presidents Budget, FY 2017 Issue: Funding for Agency for Healthcare Research and Quality (AHRQ), NIH Presidents Budget, FY 2016 H.R. 3020/S. 1695, House Labor, HHS, Education and Related Agencies Act, 2016, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose House proposal to eliminate AHRQ. Oppose rescissions from CMMI and PCORI. President's Budget, FY 2016 H.R. 4486 and draft Senate House Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2015 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Oppose discretionary spending cuts through sequestration, including NIH and other science programs. Issue: Supporting the use of animals in medical research. Issue: Funding for pandemic preparedness and biodefense programs. Issue: Draft legislation on protections for human subjects in research. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 320/H.R. 744, Medical Innovation Act Issue: Requires covered manufacturers of blockbuster drugs developed, in whole or in part, through federal investments in medical research that enter settlement agreements with a federal agency to pay 1 percent of net income over five years to increase congressional investments in biomedical research. S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. H.R. 6, 21st Century Cures Act Senate HELP Committee Innovation Initiative Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. H.R. 2102, Research for All Act of 2015 Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research. Issue: FDA regulation of Laboratory Developed Tests (LDTs) H.R. 3466/S. 2014, Next Generation Research Act Issue: Support National Institutes of Health programs for new and young scientists. H.R. 1806, The America COMPETES Act of 2015 Issue: Support increased funding for the National Science Foundation (NSF) Issue: Support federal funding for research using human fetal tissue. Submitted comments to: National Institute on Minority Health and Health Disparities (NIMHD) on interdisciplinary training in health disparities science The White House on the Precision Medicine Initiatives proposed privacy and trust principles National Institutes of Health (NIH) on the framework for the NIH-wide Strategic Plan NIMHD on the NIH Science Vision for health disparities research
2015 · third_quarter · Health Issues
S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research
Client expense: $58,549 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Health Issues
21st Century Cures Act (HR 6), NIH Administrative Issues/Senate HELP Innovation Initiative, Organ transplantation issues, Graduate Medical Education, Indirect Medical Education Funding, Chronic care management billing/CMS, Next Generation Researchers Act (S. 2014, HR 3466)
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
| Democratic |
| OR |
| Eric Swalwell | Democratic | CA |
| Grace Meng | Democratic | NY |
| Janice D. Schakowsky | Democratic | IL |
| Mark Takai | Democratic | HI |
| Mark Takano | Democratic | CA |
| Matt Cartwright | Democratic | PA |
| Michael M. Honda | Democratic | CA |
| Peter A. DeFazio | Democratic | OR |
| Peter Welch | Democratic | VT |
| Raúl M. Grijalva | Democratic | AZ |
| Ron Kind | Democratic | WI |
| Steve Cohen | Democratic | TN |
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $15,681 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $36,139 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Client expense: $780,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $780,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Client expense: $820,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $820,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office